44 results found
Searchresult 1 - 10 of 44. You filter by “Abuse of dominant position”.
-
ACM extends its investigation into orphan drug CDCA-Leadiant
ACM extends its investigation into the orphan drug CDCA manufactured by Leadiant. The investigation focuses on the pricing of the drug, and on possible abuse of a dominant position.
-
ACM’s oversight during the Coronavirus crisis
What does ACM do during the current coronavirus (COVID-19) outbreak? More information about its oversight, the rules and regulations that apply, and how ACM can be reached.
-
ACM has appointed five new Non-Governmental Advisors
ACM has appointed five new Non-Governmental Advisors (NGAs). One of their duties is to help promote international cooperation in the world of competition.
-
European competition authorities and oversight during the Coronavirus crisis
The European competition authorities have released a joint statement: companies are allowed to work together in order to combat the Coronavirus (COVID-19) crisis.
-
Insurers do not distort competition on the auto-body repair market
Many small auto-body repair businesses have trouble staying afloat. This is not the result of anticompetitive conduct by insurers, but rather the result of market developments. This has been one of the conclusions of an ACM study into the market for auto-body repair services.
-
ACM investigates price-fixing agreements between consumer-goods manufacturers and retailers
ACM is investigating price-fixing agreements between consumer-goods manufacturers and retailers (including online). It is suspected that some manufacturers are trying to conclude minimum-price agreements with retailers.